31-05-2021 Anticoagulation historical overview on Warfarin development and DOACs overview

See more from BLOODSA

Haem Deep Dive

09-09-2024 Aspects of Diffuse Large B-cell Lymphoma in Johannesburg

September 9, 2024

BMT Classroom

04-09-2024 BMT Classroom

This content is only available to members.

September 4, 2024

Haem Deep Dive

02-09-2024 The Evolution of CML Treatment

September 2, 2024

All resources showcased on this website are provided by BLOODSA in collaboration with our partners. It may be used and shared for non-commercial purposes only with proper acknowledgement to BLOODSA and respective authors (if applicable) and the information must remain accessible in the public domain.

We are in Strategic Partnership with:

Room E4-58, E5 Haematology Clinic E-floor, New Main Building, Groote Schuur Hospital, Observatory, CAPE TOWN 7935

+27 (0) 21 404 3070 | admin@bloodsa.org.za

BLOODSA Foundation NPC is registered in South Africa with Company Reg. No: 2021/990954/08, Non-Profit Organisation Reg. No: 268-421 NPO and Public Benefit Organisation Ref. No: 930076265

About
Services
Contact
Consortium Agreement
Code of Coduct
Cookie Policy
Privacy Policy
Popia Statement

About
Services
Contact
Consortium Agreement
Code of Coduct
Cookie Policy
Privacy Policy
Popia Statement

Scroll to Top

31-05-2021 Anticoagulation historical overview on Warfarin development and DOACs overview

See more from BLOODSA

09-09-2024 Aspects of Diffuse Large B-cell Lymphoma in Johannesburg

04-09-2024 BMT Classroom

02-09-2024 The Evolution of CML Treatment

BACK TO RESOURCES